Our Summary

This research paper examines the use of a specific product, derived from fetal cows, in breast reconstruction surgery. It is called SurgiMend and it comes in different variations. The paper looks at the safety of using this product, how successful surgeries using it have been, and the various surgical methods it is used in. The main goal is to continue improving the results and patient experiences in breast reconstruction.

FAQs

  1. What is the role of fetal bovine-derived acellular dermal matrix in breast reconstruction?
  2. What are the safety considerations when using SurgiMend, SurgiMend PRS and SurgiMend PRS meshed in breast reconstruction?
  3. How have surgical techniques evolved in breast reconstruction using these products?

Doctor’s Tip

One helpful tip a doctor might tell a patient about breast reconstruction is to discuss the options of using acellular dermal matrix, such as SurgiMend, during the reconstruction process. This product can help provide support and structure for the reconstructed breast, leading to better aesthetic outcomes and improved healing. It is important for patients to be informed about the benefits and potential risks of using acellular dermal matrix in their reconstruction surgery.

Suitable For

Patients who have undergone mastectomy for breast cancer or have undergone prophylactic mastectomy due to a high risk of breast cancer are typically recommended for breast reconstruction. Other patients who may be recommended for breast reconstruction include those who have undergone lumpectomy or have experienced trauma or deformities of the breast. It is important for patients to discuss their options with their healthcare provider to determine if breast reconstruction is the right choice for them.

Timeline

Before breast reconstruction:

  • Patient is diagnosed with breast cancer or undergoes mastectomy
  • Patient consults with plastic surgeon to discuss reconstruction options
  • Patient and surgeon decide on the best approach for reconstruction (implants, autologous tissue, etc.)
  • Patient undergoes tissue expansion if necessary
  • Surgical date is scheduled for breast reconstruction

After breast reconstruction:

  • Patient undergoes surgery for breast reconstruction
  • Patient may experience discomfort, swelling, and bruising post-operatively
  • Patient follows post-operative care instructions provided by surgeon
  • Patient attends follow-up appointments with surgeon to monitor healing and address any concerns
  • Patient may undergo additional procedures for symmetry or nipple reconstruction
  • Patient continues to monitor breast health and follow-up with oncologist for cancer surveillance.

What to Ask Your Doctor

  1. What are the different options available for breast reconstruction using acellular dermal matrix?

  2. How does the use of fetal bovine-derived acellular dermal matrix compare to other materials or techniques for breast reconstruction?

  3. What are the potential risks and complications associated with using acellular dermal matrix for breast reconstruction?

  4. How long does the recovery process usually take when using acellular dermal matrix for breast reconstruction?

  5. Are there any specific factors that may make me a better candidate for breast reconstruction using acellular dermal matrix?

  6. How will the use of acellular dermal matrix affect the aesthetic outcome of my breast reconstruction?

  7. What post-operative care or follow-up will be necessary after undergoing breast reconstruction with acellular dermal matrix?

  8. Can you provide me with information on the success rates and patient satisfaction outcomes of using acellular dermal matrix for breast reconstruction?

  9. Are there any alternative options for breast reconstruction that I should consider before making a decision?

  10. Can you explain the surgical technique that will be used when incorporating acellular dermal matrix into my breast reconstruction procedure?

Reference

Authors: Bassetto F, Pandis L. Journal: Br J Hosp Med (Lond). 2020 Mar 2;81(3):1-18. doi: 10.12968/hmed.2018.0428c. Epub 2020 Mar 4. PMID: 32240008